Zobrazeno 81 - 90
of 1 642
pro vyhledávání: ''
Autor:
Kazuki Ohya, Kazuaki Chayama, Tomokazu Kawaoka, Masami Yamauchi, Maiko Namba, Takashi Nakahara, Michio Imamura, Kei Morio, Eisuke Murakami, Kenichiro Kodama, Shinsuke Uchikawa, Akira Hiramatsu, Hiroshi Aikata
Publikováno v:
Oncology. 97:75-81
Aim: This study investigated early tumor marker response and treatment response in patients with advanced hepatocellular carcinoma (HCC) treated with lenvatinib. Methods: Twenty patients with advanced HCC who received lenvatinib were enrolled in this
Autor:
Tsunekazu Mizushima, Chu Matsuda, Masaki Mori, Ichiro Takemasa, Naotsugu Haraguchi, Hidekazu Takahashi, Junichi Nishimura, Taroh Satoh, Daisuke Sakai, Toshihiro Kudo, Tsuyoshi Hata, Taishi Hata, Yuichiro Doki
Publikováno v:
Oncology. 97:211-216
Objectives: The aim of this study was to determine the recommended dose (RD) of capecitabine combined with oxaliplatin and irinotecan (XELOXIRI) as a neoadjuvant chemotherapy in patients with locally advanced rectal cancer. Method: Patients received
Autor:
Giusi Santangelo, Carolina Maria Sassu, Innocenza Palaia, Giorgia Perniola, Federica Tomao, Antonella Giancotti, Angela Musella, Violante Di Donato, Anna Di Pinto, Pierluigi Benedetti Panici
Publikováno v:
Oncology. 97:306-310
Background: Chemotherapy at the end of life is a complex and challenging problem in medical oncology. Patients affected by ovarian cancer (OC) often experience a chronicization and slow progression of their disease, and chemotherapy is proposed until
Autor:
Mariela A. Blum Murphy, Irene Thomas, Jane E. Rogers, Elizabeth Sanders, Jaffer A. Ajani, Fatemeh G. Amlashi, Namita Shanbhag, Lianchun Xiao, Elena Elimova
Publikováno v:
Oncology. 96:252-258
Background: The RAINBOW trial established ramucirumab combined with paclitaxel as a second-line option in metastatic gastric and gastroesophageal junction (GEJ) adenocarcinoma. Ramucirumab was given on days 1 and 15 with paclitaxel on days 1, 8, and
Autor:
Do Hoon Lim, Joon-Ho Lee, Filippo Pietrantonio, Seung Tae Kim, Federica Morano, Min Gew Choi, Won Ki Kang, Kyoung-Mee Kim, Giovanni Fucà, Jae Moon Bae, Tae Sung Sohn, Se Hoon Park, Maria Di Bartolomeo, Sung Kim, Jiyeong An, Rosalba Miceli, Jeeyun Lee, Alessandra Raimondi
Publikováno v:
Oncology. 97:38-43
Background: Caucasian patients with microsatellite instability (MSI)-high gastric cancer (GC) may have better prognosis but worse outcomes. Objective: Here we explored the prognostic role of MSI in Asian patients. Methods: This post hoc analysis comp
Autor:
Kazuo Kobayashi, Takeshi Aoyama, Kensei Yamaguchi, Mitsukuni Suenaga, Takashi Yokokawa, Takeru Wakatsuki, Kenichi Suzuki, Toshihiro Hama, Kazuyoshi Kawakami, Erika Sugiyama, Hitoshi Sato
Publikováno v:
Oncology. 96:200-206
Purpose: Hand-foot skin reaction (HFSR) can deteriorate quality of life in patients receiving regorafenib. Cutaneous toxicity is a main adverse effect of multikinase inhibitors and has also been associated with clinical outcome. This study assessed t
Publikováno v:
Oncology. 96:183-191
Purpose: Cancer-related fatigue is one of the most debilitating side effects of cancer and cancer therapy. We aimed to investigate co-occurring symptoms associated with persistent fatigue in men receiving external beam radiation therapy (EBRT) for no
Autor:
Masatoshi Tanaka, Toshi Abe, Naoki Kamachi, Mika Nomiyama, Ryoko Kuromatsu, Masahito Nakano, Takashi Niizeki, Hiroyuki Suzuki, Hideki Iwamoto, Takuji Torimura, Etsuyo Ogo, Manabu Satani, Syusuke Okamura, Hironori Koga, Shigeo Shimose, Miwa Sakai, Yu Noda, Tomotake Shirono
Publikováno v:
Oncology. 96:192-199
Aim: Prognosis of hepatocellular carcinoma (HCC) with macrovascular invasion (MVI) is extremely poor. However, proper therapeutic strategies have not been established yet. The purpose of this study is to identify the effects of external beam radiatio
Autor:
Kun-Huei Yeh, Li Hui Tseng, Been-Ren Lin, Liang-In Lin, Yu-Lin Lin, Kuo-Hsing Chen, Jin-Tung Liang, Jia-Huei Tsai, Ann-Lii Cheng, Jau-Yu Liau
Publikováno v:
Oncology. 96:156-163
Objective: We aimed to study the prognostic role of CpG island methylator phenotype (CIMP) in patients with different stages of colorectal cancer (CRC). Material and Methods: We analyzed CIMP in stage I–IV CRC specimens from patients who were diagn
Autor:
Takanori Hirai, Takeshi Hiramatsu, Shinya Maruta, Eizaburo Ohno, Kuroiwa M, Hiroshi Matsubara, Takuya Ishikawa, Masashi Hattori, Tomoyuki Tsuzuki, Koichi Achiwa, Hajime Sumi, Yoshiki Hirooka, Akira Kanamori, Yoji Sasaki, Koji Nonogaki, Masahiko Ando, Hiroki Kawashima, Senju Hashimoto
Publikováno v:
Oncology. 96:1-7
Objective: To evaluate the efficacy and safety of alternate-day administration of S-1 as second-line chemotherapy for unresectable pancreatic cancer in a multicenter, randomized, phase II study. Methods: Patients with histologically proven, unresecta